Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the

Anila Duni1, Vassilios Liakopoulos2, Karolos-Pavlos Rapsomanikis1

  • 1Department of Nephrology, Medical School of the University of Ioannina, Ioannina, Greece.

Insights

Chronic kidney disease (CKD) patients face high cardiovascular disease risk due to increased oxidative stress. This review highlights how oxidative stress contributes to cardiovascular damage and reduced lifespan in CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Oxidative Stress Research

Background:

  • Chronic kidney disease (CKD) is linked to a significantly increased risk of cardiovascular disease (CVD) and reduced lifespan.
  • CKD exacerbates oxidative stress through elevated reactive oxygen species (ROS) production and diminished antioxidant defenses.

Purpose of the Study:

  • To elucidate the mechanisms by which oxidative stress contributes to cardiovascular complications in CKD.
  • To review the role of oxidative stress pathways in the development of left ventricular hypertrophy (LVH) and cardiorenal syndrome.
  • To highlight the significance of paraoxonase-1 (PON1) activity in CKD-related cardiovascular risk.

Main Methods:

  • Review of existing literature on oxidative stress in CKD and its cardiovascular implications.
  • Analysis of pathophysiological pathways including the intrarenal angiotensin system, NADPH oxidase, and xanthine oxidase.
  • Examination of the role of impaired antioxidant enzymes like PON1.

Main Results:

  • Increased ROS production in CKD, partly mediated by the intrarenal angiotensin system, drives cardiovascular damage.
  • Oxidative stress promotes lipid peroxidation, protein carbamylation, endothelial dysfunction, and inflammation, accelerating atherosclerosis.
  • Reduced serum PON1 activity in CKD patients is associated with a higher burden of cardiovascular disease.

Conclusions:

  • Oxidative stress is a key factor in the pathogenesis of cardiovascular disease in CKD patients.
  • Targeting oxidative stress pathways may offer a therapeutic strategy for managing cardiovascular complications in CKD.
  • Further research is warranted to evaluate the efficacy of antioxidant therapies in CKD.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
780
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
705
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
490
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
419
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
588
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K